Tafazzin Polyclonal Antibody, AbBy Fluor-350 Conjugated, BF350, Rabbit

Catalog Number: BSS-BS-15504R-BF350
Article Name: Tafazzin Polyclonal Antibody, AbBy Fluor-350 Conjugated, BF350, Rabbit
Biozol Catalog Number: BSS-BS-15504R-BF350
Supplier Catalog Number: bs-15504R-BF350
Alternative Catalog Number: BSS-BS-15504R-BF350-100
Manufacturer: Bioss
Host: Rabbit
Category: Antikörper
Application: IF, WB
Conjugation: BF350
Alternative Names: Barth syndrome, Cardiomyopathy dilated 3A X linked, EFE2, Endocardial fibroelastosis 2, Protein G4.5, Tafazzin, TAZ, TAZ protein, TAZ protein, TAZ_HUMAN.
This gene encodes a protein that is expressed at high levels in cardiac and skeletal muscle. Mutations in this gene have been associated with a number of clinical disorders including Barth syndrome, dilated cardiomyopathy (DCM), hypertrophic DCM, endocardial fibroelastosis, and left ventricular noncompaction (LVNC). Multiple transcript variants encoding different isoforms have been described. A long form and a short form of each of these isoforms is produced, the short form lacks a hydrophobic leader sequence and may exist as a cytoplasmic protein rather than being membrane-bound. Other alternatively spliced transcripts have been described but the full-length nature of all these transcripts is not known.
Clonality: Polyclonal
Concentration: 1ug/ul
NCBI: 6901
Buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Source: KLH conjugated synthetic peptide derived from human Tafazzin
Target: Tafazzin
Application Dilute: WB(1:300-5000), IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)